Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia

Hui Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hua Jiang(Renji Hospital)
Clinical Cancer Research
April 8, 2021
Cited by 101


Related Papers